Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Ophthalmology Clerkship
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • People First
  • Events
  • Giving
  • News

An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation.

Posted on May 1, 2024

PubMed ID: 38635428 Author(s): Weinlander E, Erb B, Thiessen C. An Eye for an Eye?: Problematic Risk-Benefit Trade-Offs in Whole Eye Transplantation. Am J Bioeth. 2024 May;24(5):75-79. doi: 10.1080/15265161.2024.2328285. Epub 2024 Apr 18. No abstract …

Posted in Eric Weinlander, Publications

Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease.

Posted on April 16, 2024

PubMed ID: 38625674 Author(s): Maganti N, Whittier SA, Warner EJ. Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease. J Ophthalmic Inflamm Infect. 2024 Apr 16;14(1):15. …

Posted in Evan Warner, Publications

Fluorimetric detection of DNA methylation by cerium oxide nanoparticles for early cancer diagnosis.

Posted on April 15, 2024

PubMed ID: 38586346 Author(s): Adampourezare M, Nikzad B, Amini M, Sheibani N. Fluorimetric detection of DNA methylation by cerium oxide nanoparticles for early cancer diagnosis. Heliyon. 2024 Mar 23;10(7):e28695. doi: 10.1016/j.heliyon.2024.e28695. eCollection 2024 Apr 15. …

Posted in Publications, Sheibani Lab

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion.

Posted on April 1, 2024

PubMed ID: 38061584 Author(s): Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA; SCORE2 Investigator Group. Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central …

Posted in Barbara Blodi, Publications, WRC

Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes.

Posted on March 13, 2024

PubMed ID: 38559222 Author(s): Liu TYA, Huang J, Channa R, Wolf R, Dong Y, Liang M, Wang J, Abramoff M. Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes. Res Sq …

Posted in Publications, Roomasa Channa

A Case of Rhegmatogenous Retinal Detachment in Chronic Myeloid Leukemia.

Posted on March 4, 2024

PubMed ID: 38437797 Author(s): Maganti N, Crabtree GS, Chang JS, Schildroth KR. A Case of Rhegmatogenous Retinal Detachment in Chronic Myeloid Leukemia. Retin Cases Brief Rep. 2024 Mar 4. doi: 10.1097/ICB.0000000000001562. Online ahead of print. …

Posted in Gordon Crabtree, Jonathan Chang, Publications

Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes.

Posted on March 4, 2024

PubMed ID: 38446483 Author(s): Liu TYA, Shpigel J, Khan F, Smith K, Prichett L, Channa R, Kanbour S, Jones M, Abusamaan MS, Sidhaye A, Mathioudakis N, Wolf RM. Use of Diabetes Technologies and Retinopathy in …

Posted in Publications, Roomasa Channa

POLARIS

Posted on March 2, 2024

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene (POLARIS)

Posted in Actively Recruiting, Clinical Trials, Kimberly Stepien, Stargardt Disease

DRCR AL

Posted on March 2, 2024

A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy (Protocol AL)

Posted in Actively Recruiting, Choroidal Melanoma, Clinical Trials, Michael Altaweel
  • Previous page
  • 1
  • 11
  • 12
  • You're on page 13
  • 14
  • 15
  • 609
  • Next page

Archives

Categories

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.